BioPharma Business Development Supervisor
Agilent Technologies
Wilmington, Delaware
Christopher Colangelo, PhD, MBA is the Agilent Biopharma Business Development Leader for the Americas. Prior to joining Agilent, he was the 5th employee and co-inventor of the 454-sequencing platform. In 2003, Chris joined Yale University as a Research Faculty in where he mentored and supervised a research group producing 60+ peer-reviewed publications and directed core research laboratories for four NIH P30 grants, totaling over $21 million worth of research funds. In 2017, Chris joined Agilent to lead the team helping customers develop, test, and implement end-to-end biopharmaceutical workflows.
Disclosure information not submitted.
Comprehensive Analytical Workflows for Characterization & Quality Control of mRNA-LNP Therapeutics
Tuesday, May 6, 2025
12:15 PM - 1:00 PM ET